Validation and Cultural Adaptation of Jaw Functional Limitation Scale-20
Alidation and Cultural Adaptation of Jaw Functional Limitation Scale-20 in Greek Population
1 other identifier
observational
200
1 country
1
Brief Summary
Temporomandibular joint (TMJ) disorder (TMD) is common. Jaw Functional Limitation Scale-20 (JFLS) is a validated tool for the evaluation of patients suffering from TMD
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
May 1, 2026
9 months
May 3, 2026
August 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Jaw Functional Limitation Scale-20
Patients suffering from TMJD will be assessed with the JFLS-20 for the validation and cultural adaptation of the JFLS-20 for the assessment of jaw functional limitation
"From enrollment (baseline) to the end of assessment at 1 week"
Study Arms (1)
Patients suffering from temporomandibular joint disorder
each patient will complete the translated in the greek language JFLS-20 and the 14-item Oral Health Impact Profile (OHIP-14) twice
Eligibility Criteria
Patients treated for temporomandibular joint disorders in UHL
You may qualify if:
- adult patient \>18 years old
- native speakers of the Greek language
- willing to participate
You may not qualify if:
- any diagnosed neurocognitive dysfunction
- any diagnosed systematic disease that forbids the participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Larissa University Hospital
Larissa, Thessaly, 41110, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anaesthesiology
Study Record Dates
First Submitted
May 3, 2026
First Posted
August 27, 2026
Study Start
November 1, 2025
Primary Completion
August 1, 2026
Study Completion
August 17, 2026
Last Updated
August 27, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share